1. Home
  2. SNOA vs CPHI Comparison

SNOA vs CPHI Comparison

Compare SNOA & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • CPHI
  • Stock Information
  • Founded
  • SNOA 1999
  • CPHI N/A
  • Country
  • SNOA United States
  • CPHI China
  • Employees
  • SNOA N/A
  • CPHI N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNOA Health Care
  • CPHI Health Care
  • Exchange
  • SNOA Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • SNOA 6.4M
  • CPHI 7.3M
  • IPO Year
  • SNOA 2007
  • CPHI N/A
  • Fundamental
  • Price
  • SNOA $3.61
  • CPHI $1.94
  • Analyst Decision
  • SNOA
  • CPHI
  • Analyst Count
  • SNOA 0
  • CPHI 0
  • Target Price
  • SNOA N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • SNOA 74.2K
  • CPHI 178.4K
  • Earning Date
  • SNOA 08-07-2025
  • CPHI 08-13-2025
  • Dividend Yield
  • SNOA N/A
  • CPHI N/A
  • EPS Growth
  • SNOA N/A
  • CPHI N/A
  • EPS
  • SNOA N/A
  • CPHI N/A
  • Revenue
  • SNOA $14,288,000.00
  • CPHI $4,295,377.00
  • Revenue This Year
  • SNOA $38.54
  • CPHI N/A
  • Revenue Next Year
  • SNOA N/A
  • CPHI N/A
  • P/E Ratio
  • SNOA N/A
  • CPHI N/A
  • Revenue Growth
  • SNOA 12.20
  • CPHI N/A
  • 52 Week Low
  • SNOA $1.75
  • CPHI $1.20
  • 52 Week High
  • SNOA $9.37
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 62.41
  • CPHI 52.91
  • Support Level
  • SNOA $2.97
  • CPHI $1.62
  • Resistance Level
  • SNOA $3.04
  • CPHI $1.88
  • Average True Range (ATR)
  • SNOA 0.23
  • CPHI 0.16
  • MACD
  • SNOA 0.09
  • CPHI 0.02
  • Stochastic Oscillator
  • SNOA 59.71
  • CPHI 80.56

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: